AzTrials
AzTrials

Autism Spectrum DisordersNCT02139514

Virtual Reality Social Cognition Training for Adults With Autism Spectrum Disorders

A study testing Virtual Reality Social Cognition Training in people with Autism Spectrum Disorders, run by Yale University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to predict and explain on the basis of brain function and structure the behavioral and brain effects of an evidence-based intervention for adults with high-functioning autism, Virtual Reality-Social Cognition Training (Kandalaft et al., 2012; Journal of Autism and Developmental Disorders). Read more about this study

Who is it for?
Ages 18 to 40 years, men onlyHealthy volunteers can take part
Conditions the study is for
Autism Spectrum Disorders
What is being tested?
Virtual Reality Social Cognition Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteUnited States
Study dates
Jan 2013to Jun 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Adults:
  • Age: 18-40, inclusive
  • A male or female outpatient
  • High-functioning (so that the treatment can effectively benefit the subjects):
  • Full Scale Intelligence Quotient (IQ) of WASI at least 80
  • Able to give informed consent prior to initiation of any protocol required procedures
Show all 10Show fewer
  • Autism Spectrum Disorder:
  • Having a current primary diagnosis of Autism Spectrum Disorder (including Asperger's Disorder) from a licensed psychologist/psychiatrist or from a school diagnostician, as defined by the DSM-IV criteria.
  • For this project, diagnosis will not be determined by our assessment. The participants we enroll will already carry a current primary diagnosis of Autism Spectrum Disorder. This verification of their diagnosis may also come from study personnel who have seen and/or treated the patient prior to his or her involvement in the project and can verbally confirm that they carry the proper diagnosis.
  • Mean Length of Utterance (MLU) must be at least 4-5 words (the intervention method requires this)

Who cannot join

  • Speech-language criteria:
  • Those who are not fluent in written and oral English will not be eligible to participate, as many of the instruments are not validated in other languages.
  • Significant hearing loss or other severe sensory impairment
  • Inability to read self-report instruments
  • Health criteria:
  • Those whose clinical status (e.g., serious suicidal or homicidal risk) requires inpatient or day hospital treatment
Show all 21Show fewer
  • Those with a history of seizures, or current use of anticonvulsants
  • A fragile health status
  • A history of significant head trauma or serious brain or psychiatric illness
  • Having any other current psychiatric condition or complications, such as
  • Diagnosed with substance dependence within the last three months. ii. Current use of prescription medications that may affect cognitive processes under study.
  • Current primary diagnosis of bipolar disorder I or II iv. Axis I psychopathology v. Depression
  • Any metal or electromagnetic implants, including:
  • Cardiac pacemaker
  • Defibrillator
  • Artificial heart valve
  • Aneurysm clip
  • Cochlear implants
  • Shrapnel
  • Neurostimulators
  • History of metal fragments in eyes or skin

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Yale University

    New Haven, Connecticut, 06520

Other trials in United States

About this study

The purpose of this study is to predict and explain on the basis of brain function and structure the behavioral and brain effects of an evidence-based intervention for adults with high-functioning autism, Virtual Reality-Social Cognition Training (Kandalaft et al., 2012; Journal of Autism and Developmental Disorders). Adults with autism will be randomly assigned to receive either (a) two hours per week of intervention services for five weeks, or (b) a treatment as usual control. The intervention will focus on enhancing social skills, social cognition, and social functioning. Outcome measures will evaluate changes in these social skills, cognition, and functioning using standardized assessments. We will perform structural and functional magnetic resonance imaging (MRI) scans at three time points-before, during, and after treatment (i.e., Time Point #1, 2, and 3).

Read the detailed description

The purpose of this study is to predict and explain on the basis of brain function and structure the behavioral and brain effects of an evidence-based intervention for adults with high-functioning autism, Virtual Reality-Social Cognition Training (Kandalaft et al., 2012; Journal of Autism and Developmental Disorders). Adults with autism will be randomly assigned to receive either (a) two hours per week of intervention services for five weeks, or (b) a treatment as usual control. The intervention will focus on enhancing social skills, social cognition, and social functioning. Outcome measures will evaluate changes in these social skills, cognition, and functioning using standardized assessments. We will perform structural and functional magnetic resonance imaging (MRI) scans at three time points-before the treatment, after the treatment, and a 3-month follow-up (i.e., Time Point #1, 2, and 3).

All the recruitment will be taking place at Yale Child Study Center (YCSC), while the intervention will be delivered online by therapists located at the Center for BrainHealth at the University of Texas at Dallas (UTD). The intervention is called Virtual Reality-Social Cognition Training (VR-SCT) and has been approved by the IRB at UTD (approval number #06-54).

Being tested
Virtual Reality Social Cognition Training
Keywords
Social Skills, Adults
Medical subject headings
Autism Spectrum Disorder, Social Skills

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality Social Cognition TrainingBehavioural

    Social skills training via virtual reality with trained therapist.

Study groups in NCT02139514
Study groupRoleWhat they receive
Virtual Reality Social Cognition TrainingActive comparatorVirtual Reality Social Cognition Training
Receives: Behavioral: Virtual Reality Social Cognition Training
ControlNo interventionParticipants in the Control condition will be offered treatment following the Control condition.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. functional magnetic resonance imaging (MRI)

    Measured: up to 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 May 2014 (estimated)
  2. Study startJan 2013
  3. Primary completionJun 2016
  4. Study completionJun 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02139514
Sponsor's protocol ID
1211011083
Status last verified
Oct 2016
First submitted
13 May 2014
Last updated
26 Oct 2016
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Social Cognition Training in people with Autism Spectrum Disorders, run by Yale University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 21 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

functional magnetic resonance imaging (MRI) (time frame: up to 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in